Gangliosidosis GM1 type 3

A ganglioside storage disorder caused by beta-galactosidase (EC 3.2.1.23) deficiency with resulting accumulation of excessive amounts of ganglioside GM1 in the brain tissue with less severe abnormalities than those seen in other gangliosidoses and inconsistent phenotype. Onset takes place in late teens or early adult life with cerebellar dysfunction, visual problems, and coarsening of facial features. Intellectual impairment is mild at first but intelligence tends to deteriorate in time.

Chemwatch
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.